Alphatec Holdings, Inc. key statistics and ratios
In fiscal 2025, Alphatec Holdings, Inc. had an operating margin of -10.7%, debt equal to 5566.3% of equity and a current ratio of 2.06. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 67.2% | 65.7% | 59.1% | 63.1% | 60.7% | 70.9% | 65.5% | 63.3% | 67.1% | 69.0% | 68.4% | 70.8% | 64.9% | 66.4% | 64.3% | 69.4% | 69.6% | 71.3% |
| Operating margin | −8.4% | −6.9% | −12.4% | −5.0% | −35.9% | 1.0% | −130.9% | −12.8% | −8.8% | −24.5% | −41.7% | −40.6% | −52.7% | −41.9% | −36.0% | −22.3% | −10.7% | −3.6% |
| Net margin | −11.0% | −8.4% | −11.2% | −7.9% | −40.2% | −8.3% | −133.0% | −24.9% | −2.3% | −31.6% | −50.3% | −54.5% | −58.8% | −43.1% | −38.7% | −26.5% | −18.8% | −10.3% |
| Free-cash-flow margin | −14.4% | −16.8% | 2.6% | −2.1% | −3.2% | −20.4% | −1.6% | −15.7% | −16.0% | −35.0% | −40.7% | −48.0% | −58.3% | −35.5% | −33.0% | −20.9% | 0.4% | 0.4% |
| Return on equity | −17.8% | −8.4% | −8.7% | −6.3% | −39.4% | −8.0% | — | — | — | — | −186.3% | −91.1% | −135.9% | — | — | — | — | — |
| Return on assets | — | −3.8% | −6.0% | −4.1% | −22.0% | −3.6% | −72.7% | −24.9% | −2.6% | −27.1% | −38.1% | −36.6% | −34.3% | −27.7% | −28.1% | −20.5% | −18.3% | −10.9% |
| Asset turnover | — | 0.46 | 0.53 | 0.52 | 0.55 | 0.44 | 0.55 | 1.00 | 1.14 | 0.86 | 0.76 | 0.67 | 0.58 | 0.64 | 0.73 | 0.77 | 0.98 | 1.06 |
| Current ratio | — | 2.82 | 2.04 | 2.15 | 1.43 | 1.78 | 0.81 | 1.81 | 2.24 | 2.47 | 2.98 | 3.16 | 3.28 | 1.84 | 2.86 | 2.73 | 2.06 | 2.36 |
| Debt to equity | 0.0% | 12.8% | 11.5% | 17.0% | 32.0% | 59.2% | — | — | — | 280.6% | 140.3% | 42.3% | 416.6% | — | 674.1% | — | >999% | — |
| Interest cover (operating income ÷ interest) | n/m | n/m | n/m | n/m | n/m | 0.5x | n/m | n/m | — | — | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m |
| R&D as % of revenue | 11.2% | 9.6% | 8.5% | 7.6% | 6.9% | 10.9% | 13.2% | 7.7% | 4.8% | 10.7% | 12.2% | 12.9% | 13.2% | 12.5% | 14.5% | 13.2% | 10.0% | 9.1% |
| SG&A as % of revenue | — | — | — | — | — | — | — | — | 68.8% | 79.2% | 89.7% | 89.2% | 94.3% | 85.5% | 77.6% | 73.6% | 65.2% | 63.4% |
| Capital spending as % of revenue | 9.8% | 8.2% | 4.2% | 8.0% | 7.0% | 7.3% | 9.1% | 7.4% | 7.5% | 7.1% | 11.5% | 16.0% | 28.2% | 14.1% | 16.7% | 13.6% | 5.6% | 6.9% |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 68.8% | 68.6% | 69.6% | 69.9% | 70.2% | 71.0% | 72.2% | 71.5% |
| Operating margin | −13.5% | −26.2% | −7.1% | −8.1% | −4.1% | −11.8% | −0.9% | 1.5% |
| Net margin | −18.9% | −30.7% | −22.2% | −14.5% | −10.2% | −17.6% | −12.1% | −2.5% |
| Free-cash-flow margin | 4.8% | −8.9% | 2.8% | 2.4% | 3.6% | −5.6% | 0.3% | 2.5% |
| Current ratio | 2.73 | 2.75 | 2.88 | 1.99 | 2.06 | 1.90 | 1.89 | 2.36 |
| Debt to equity | — | — | >999% | >999% | >999% | — | — | — |
| R&D as % of revenue | 13.1% | 9.8% | 9.8% | 9.5% | 10.5% | 9.1% | 8.5% | 8.1% |
| SG&A as % of revenue | 64.9% | 75.1% | 63.9% | 63.3% | 60.4% | 71.3% | 62.8% | 59.9% |
Financial health
- Short-term assets cover short-term liabilities $427m of assets due within a year against $181m of liabilities due within a year.
- Short-term assets cover long-term liabilities Not assessable from the reported split. Not assessable.
- More cash than debt $80m of cash against $547m of debt.
- Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt $61m of operating cash flow against $547m of debt.
- Operating profit covers interest at least five times over Operating income of −$30m against $46m of interest.
Moat
Weak moat
How hard Alphatec Holdings's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 0 / 20
Cash operating profit has been a median -14.4% of total assets over 8 years.
- Pricing power 18 / 20
Gross margin has been a median 68.4%, moving by 3.7 percentage points (standard deviation) across 10 years.
- Durability 10 / 20
Operating margin has been a median -31.9%; its worst year was -50.2%.
- Cash conversion 0 / 20
Free cash flow was positive in 0 of 10 years, at a median -32.3% of revenue.
- Discipline 0 / 20
The diluted share count rose 71.2% over five years; stock-based pay has been a median 11.2% of revenue.
AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.
Compare with peers
- Orthofix Medical Inc. statistics
- Irhythm Holdings, Inc. statistics
- Varex Imaging Corp statistics
- Myriad Genetics Inc statistics
- Inspire Medical Systems, Inc. statistics
Head to head: ATEC vs OFIXATEC vs IRTCATEC vs VREXATEC vs MYGN
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies